ALEXANDRIA, Va., June 9 -- United States Patent no. 12,285,441, issued on April 29, was assigned to Holy Stone Healthcare Co. Ltd. (Taipei, Taiwan).
"Uses of glycosaminoglycan conjugates" was invented by Hua-Yang Lin (Taipei, Taiwan).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure is related to a conjugate of an active drug and a glycosaminoglycan, such as hyaluronic acid (HA). For example, the active drug can be lenalidomide, nimesulide, or gemcitabine. The conjugate of the present disclosure is useful in the treatment of certain cancers."
The patent was filed on Dec. 15, 2021, under Application No. 17/551,689.
*For further information, including images, charts and tables, please visi...